These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 3528587)
1. [Clinical evaluation of a pancreatic cancer-associated glycoprotein antigen, DU-PAN-2. I. Enzymeimmunoassay and distribution of serum values in healthy persons]. Sakurabayashi I; Yamada T; Kawai T; Yamanaka T Rinsho Byori; 1986 Jun; 34(6):705-10. PubMed ID: 3528587 [No Abstract] [Full Text] [Related]
2. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2]. Ishii M; Urabe T; Seino Y Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960 [TBL] [Abstract][Full Text] [Related]
3. [Basic studies and the reference values of cancer associated antigen CA-50]. Yoshioka H; Shitara M; Sakurabayashi I; Kawai T; Suzuki M Rinsho Byori; 1988 Feb; 36(2):171-6. PubMed ID: 3288785 [No Abstract] [Full Text] [Related]
4. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract]. Takami H; Furuuchi T; Ogata Y; Abe O Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958 [TBL] [Abstract][Full Text] [Related]
5. [Fundamental studies and reference values of cancer associated antigen NCC-ST-439]. Yoshioka H; Sakurabayashi I; Kawai T; Suzuki M Rinsho Byori; 1987 Nov; 35(11):1233-8. PubMed ID: 3327976 [No Abstract] [Full Text] [Related]
6. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925 [TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of a cancer antigen, CA 15-3, associated with breast cancer. (I) Modification of its method and reference values]. Sakurabayashi I; Kawai T; Kawaguchi R; Yonezawa M Rinsho Byori; 1986 Jan; 34(1):53-8. PubMed ID: 3457966 [No Abstract] [Full Text] [Related]
8. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347 [TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value]. Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875 [No Abstract] [Full Text] [Related]
10. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers]. Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791 [TBL] [Abstract][Full Text] [Related]
11. [Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer]. Kamachi S; Sakurabayashi I; Kawai T Rinsho Byori; 1984 Jul; 32(7):781-5. PubMed ID: 6389940 [No Abstract] [Full Text] [Related]
12. [Clinical evaluation of enzyme immunoassay for a pancreatic oncofetal antigen (POA)]. Hishinuma S; Takami H; Shintoku J; Matsui J; Uematsu S; Baba H; Ogata Y; Abe O; Ishii T; Miyoshi K Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2217-24. PubMed ID: 6398349 [No Abstract] [Full Text] [Related]
13. Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma. Loor R; Kuriyama M; Bodziak ML; Inaji H; Douglass HO; Berjian R; Nicolai JJ; Tytgat GN; Chu TM Cancer Res; 1984 Aug; 44(8):3604-7. PubMed ID: 6744282 [TBL] [Abstract][Full Text] [Related]
14. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. Papsidero LD; Nemoto T; Croghan GA; Chu TM Cancer Res; 1984 Oct; 44(10):4653-7. PubMed ID: 6088042 [TBL] [Abstract][Full Text] [Related]
15. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction. Del Favero G; Fabris C; Panucci A; Basso D; Plebani M; Baccaglini U; Leandro G; Burlina A; Naccarato R Bull Cancer; 1986; 73(3):251-5. PubMed ID: 3530354 [TBL] [Abstract][Full Text] [Related]
16. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 5). DU-PAN-2]. Sawabu N; Satomura Y; Takemori Y Nihon Rinsho; 1986 Aug; 44(8):1830-3. PubMed ID: 3537374 [No Abstract] [Full Text] [Related]
17. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Lan MS; Finn OJ; Fernsten PD; Metzgar RS Cancer Res; 1985 Jan; 45(1):305-10. PubMed ID: 3965141 [TBL] [Abstract][Full Text] [Related]
18. Purification, partial characterization, and clinical evaluation of an adenocarcinoma-associated antigen. Pinto VB; Gelder FB; Morris DM Cancer Res; 1986 Dec; 46(12 Pt 1):6520-4. PubMed ID: 3536083 [TBL] [Abstract][Full Text] [Related]
19. Circadian rhythm of serum erythropoietin in healthy subjects. Pasqualetti P; Casale R Riv Eur Sci Med Farmacol; 1996; 18(3):91-3. PubMed ID: 9177605 [TBL] [Abstract][Full Text] [Related]
20. Tissue distribution, immunochemical characterization, and biosynthesis of 47D10, a tumor-associated surface glycoprotein. Ho MK; Kato KP; Durda PJ; Murray JH; Wolfe H; Rabin H; Carney WP Cancer Res; 1987 Jan; 47(1):241-50. PubMed ID: 3539319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]